326 related articles for article (PubMed ID: 31506080)
1. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.
LoRusso S; Johnson NE; McDermott MP; Eichinger K; Butterfield RJ; Carraro E; Higgs K; Lewis L; Mul K; Sacconi S; Sansone VA; Shieh P; van Engelen B; Wagner K; Wang L; Statland JM; Tawil R;
BMC Neurol; 2019 Sep; 19(1):224. PubMed ID: 31506080
[TBL] [Abstract][Full Text] [Related]
2. Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH; Leung DG; Wagner KR; Lowry SJ; McDermott MP; Eichinger K; Higgs K; Walker M; Lewis L; Martens WB; Mul K; Sansone VA; Shieh P; Elsheikh B; LoRusso S; Butterfield RJ; Johnson N; Preston MR; Messina C; Carraro E; Tawil R; Statland J;
Neuromuscul Disord; 2023 Sep; 33(9):63-68. PubMed ID: 37400350
[TBL] [Abstract][Full Text] [Related]
3. Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.
Mul K; Heatwole C; Eichinger K; Dilek N; Martens WB; Van Engelen BGM; Tawil R; Statland JM
Muscle Nerve; 2018 Aug; 58(2):213-218. PubMed ID: 29543984
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
Varma A; Todinca MS; Eichinger K; Heininger S; Dilek N; Martens W; Tawil R; Statland J; Kissel JT; McDermott MP; Heatwole C
Muscle Nerve; 2024 Mar; 69(3):362-367. PubMed ID: 38189531
[TBL] [Abstract][Full Text] [Related]
5. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral Muscular Dystrophies.
Wagner KR
Continuum (Minneap Minn); 2019 Dec; 25(6):1662-1681. PubMed ID: 31794465
[TBL] [Abstract][Full Text] [Related]
7. Electrical impedance myography in facioscapulohumeral muscular dystrophy.
Statland JM; Heatwole C; Eichinger K; Dilek N; Martens WB; Tawil R
Muscle Nerve; 2016 Oct; 54(4):696-701. PubMed ID: 26840230
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy functional composite outcome measure.
Eichinger K; Heatwole C; Iyadurai S; King W; Baker L; Heininger S; Bartlett A; Dilek N; Martens WB; Mcdermott M; Kissel JT; Tawil R; Statland JM
Muscle Nerve; 2018 Jan; ():. PubMed ID: 29381807
[TBL] [Abstract][Full Text] [Related]
9. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
[TBL] [Abstract][Full Text] [Related]
10. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
[TBL] [Abstract][Full Text] [Related]
11. Current Therapeutic Approaches in FSHD.
Wang LH; Tawil R
J Neuromuscul Dis; 2021; 8(3):441-451. PubMed ID: 33579868
[TBL] [Abstract][Full Text] [Related]
12. Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.
Ghasemi M; Emerson CP; Hayward LJ
Cells; 2022 Feb; 11(4):. PubMed ID: 35203336
[TBL] [Abstract][Full Text] [Related]
13. Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions.
Huml RA; Uspenskaya-Cadoz O; Dawson J; Slifer Z
Ther Innov Regul Sci; 2020 Jan; 54(1):144-150. PubMed ID: 32008231
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy.
Hatch MN; Kim K; Kurillo G; Nicorici A; McDonald CM; Han JJ
Neuromuscul Disord; 2019 Jul; 29(7):503-513. PubMed ID: 31345604
[TBL] [Abstract][Full Text] [Related]
15. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
Mellion ML; Widholm P; Karlsson M; Ahlgren A; Tawil R; Wagner KR; Statland JM; Wang L; Shieh PB; van Engelen BGM; Kools J; Ronco L; Odueyungbo A; Jiang J; Han JJ; Hatch M; Towles J; Leinhard OD; Cadavid D
Neurology; 2022 Aug; 99(9):e877-e889. PubMed ID: 35750498
[TBL] [Abstract][Full Text] [Related]
17. An instrumented timed up and go in facioscapulohumeral muscular dystrophy.
Huisinga J; Bruetsch A; Mccalley A; Currence M; Herbelin L; Jawdat O; Pasnoor M; Dimachkie M; Barohn R; Statland J
Muscle Nerve; 2018 Mar; 57(3):503-506. PubMed ID: 28877559
[TBL] [Abstract][Full Text] [Related]
18. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development.
van den Heuvel A; Mahfouz A; Kloet SL; Balog J; van Engelen BGM; Tawil R; Tapscott SJ; van der Maarel SM
Hum Mol Genet; 2019 Apr; 28(7):1064-1075. PubMed ID: 30445587
[TBL] [Abstract][Full Text] [Related]
20. Predictors of functional outcomes in patients with facioscapulohumeral muscular dystrophy.
Katz NK; Hogan J; Delbango R; Cernik C; Tawil R; Statland JM
Brain; 2021 Dec; 144(11):3451-3460. PubMed ID: 34542603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
